MicroRNA panel can identify malignancy in indeterminate thyroid nodules

July 26, 2018, American Association for Cancer Research

A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.

The study is published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, by Haggi Mazeh, MD, FACS, chief of surgery, Department of Surgery, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem and senior author Iddo Ben-Dov, MD, Ph.D., Department of Nephrology and the Laboratory of Medical Transciptomics, Hadassah-Hebrew University Medical Center.

"Thyroid nodules are extremely common and occasionally harbor ," explained Mazeh. "Patients who undergo evaluation of often receive ambiguous results, and there are currently limited options for further management, representing a clinically unmet need."

Patients with suspicious nodules often receive fine needle aspiration biopsy (FNAB) to facilitate the diagnosis of malignancy. However, roughly 30 percent of who undergo this procedure encounter indeterminate results, noted Mazeh. He added that current molecular testing methods to analyze indeterminate thyroid nodules are often expensive and do not have the desired sensitivity and specificity.

Previous work conducted by Mazeh and others identified several microRNAs with altered expression in . However, the specific role that these microRNAs play in cancer development and their diagnostic utility have yet to be elucidated, explained Ben-Dov.

MicroRNAs are short non-coding RNAs that regulate cell function and play a role in cancer development.

To develop the microRNA panel, Mazeh and colleagues analyzed biopsies from 102 patients undergoing thyroidectomy. Once the was removed, ex-vivo FNAB was performed on the thyroid nodules, resulting in 274 total biopsies. Samples were categorized as benign (71 percent) or malignant (29 percent) based on pathological diagnoses, and RNA was isolated from the biopsied tissue and analyzed via deep sequencing to reveal the types and quantitites of microRNAs present.

Following sequencing, Mazeh and colleagues detected 279 microRNAs in the thyroid nodules; of these, 19 had significant differential expression between the malignant and benign samples and were chosen for the diagnostic panel.

"Many of the microRNAs identified in our panel have been noted to promote thyroid cancer proliferation, migration, and invasion, while some inhibit the proliferation of thyroid cancer cells and induce apoptosis," noted Ben-Dov.

Utilizing the microRNA diagnostic panel, Mazeh and colleagues analyzed 66 biopsies from 35 patients with indeterminate pathology and found that 22 patients had malignant thyroid nodules, while 13 patients had . Of the patients with malignancy, 15 patients were diagnosed with , and seven patients were diagnosed with follicular thyroid cancer.

The sensitivity, specificity, negative predictive value, positive predictive value, and overall accuracy of the diagnostic panel as compared to the gold standard pathology were 91 percent, 100 percent, 87 percent, 100 percent, and 94 percent, respectively.

"Our results provide a refined list of candidate microRNA for diagnostic use, and confirms the perception that microRNA quantification is a promising form of molecular pathology," said Mazeh. "Further studies are needed to test the clinical utility of this approach in prospective patients."

Limitations of the study include the use of ex-vivo FNAB biopsies, which is not an exact equivalent of the standard clinical utilization of FNAB. Furthermore, this was a single center study and should be validated in additional locations, Ben-Dov noted.

Explore further: Ultrasound guidelines identify children who should be biopsied for thyroid cancer

More information: Cancer Epidemiology, Biomarkers & Prevention, DOI: 10.1158/1055-9965.EPI-18-0055

Related Stories

Ultrasound guidelines identify children who should be biopsied for thyroid cancer

May 18, 2018
A Loyola Medicine study has found that new ultrasound guidelines can reliably identify pediatric patients who should be biopsied for thyroid cancer.

All thyroid cancers are not 'created equal'— avoiding unnecessary or 'excessive' treatment

July 25, 2018
More Americans are being diagnosed with thyroid cancer than ever before—over the past 25 years its incidence has tripled. This year alone, more than 50,000 people in the U.S., the majority of them of women, will receive ...

Next-gen sequencing test identifies cancerous thyroid nodules with high degree of accuracy

September 15, 2015
A next-generation sequencing test is successfully predicting which thyroid nodules are cancerous and require surgical removal, reducing the need for multiple invasive diagnostic procedures, according to researchers at the ...

Data reaffirms test's ability to identify benign thyroid nodules

October 24, 2013
Aurora, CO (Oct. 23, 2013) The latest study co-led by a CU School of Medicine researcher has confirmed that a Gene Expression Classifier (GEC) test can drastically reduce the problem of unnecessary surgeries in thyroid nodule ...

Improving diagnosis of thyroid nodules

September 6, 2012
Thyroid nodules are thought to be present in about half of all people, but very few of these are cancerous. New research published in BioMed Central's open access journal BMC Cancer presents a set of diagnostic biomarkers ...

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.